Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin on Platelet Function in Diabetic Patients (EDGE)
NCT04400760Phase 3Completed
- Sponsor
- The University of the West Indies
- Start
- May 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), sponsored by The University of the West Indies. Started May 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04400760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400760.